A ten-year review of antimicrobial resistance among human Campylobacter jejuni isolates
Bulgarian One Health Journal · 2024
DOI: 10.59496/20241puh4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulgarian One Health Journal, 2024. Verfasst von Rositsa Stoyanova. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Campylobacter jejuni is a major pathogen responsible for a significant number of reported campylobacteriosis cases in the European Union. Due to underdiagnosed and underreported cases, there are no existing studies on this pathogen. Fluoroquinolones have been the primary treatment for campylobacteriosis for many years. Fluoroquinolone resistance is causing an increase, which means that a new class of antibiotics must be introduced. The treatment of campylobacteriosis is currently based on macrolides, but with the increasing rates of resistance, active surveillance for antibiotic resistance is required. The aim of this study was to track the increasing prevalence of AMR in clinical isolates of C. jejuni across Bulgaria for a period of 10 years.
Zitieren
APA
Stoyanova, R. (2024). A ten-year review of antimicrobial resistance among human Campylobacter jejuni isolates. Bulgarian One Health Journal. https://doi.org/10.59496/20241puh4
Vancouver
Stoyanova R. A ten-year review of antimicrobial resistance among human Campylobacter jejuni isolates. Bulgarian One Health Journal. 2024. doi:10.59496/20241puh4
BibTeX
@article{Stoyanova2024,
author = {Stoyanova, Rositsa},
title = {A ten-year review of antimicrobial resistance among human Campylobacter jejuni isolates},
journal = {Bulgarian One Health Journal},
year = {2024},
doi = {10.59496/20241puh4}
}
EUVIMED